Your institution may have access to this item. Find your institution then sign in to continue.
Title
Alcon.
Abstract
The article reports that Japan's Ministry of Health, Labor and Welfare has approved VEGAMOX™ 0.5 percent solution. Alcon Inc. announced that the ministry has approved the use of the moxifloxacin hydrochloride opthalmic solution for the treatment of bacterial eye infections. Based on clinical studies, the solution showed good efficacy and therapeutic penetration. Alcon Japan president Scott Manning said that the approval means more opportunities for the company to grow in the nation.